Sindrom funktsional'noy dispepsii: aktual'nye podkhody k diagnostike i lecheniyu


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The article discloses the modern aspects of the clinical manifestation, diagnosis and treatment of the functional dyspepsia (FD). The main clinical variants of the disease and the characteristics of their course are considered. Modern algorithm, revealing the main stages of diagnosis and treatment of patients with FD in clinical practice are described. The role of proton pump inhibitors as basic drugs used in the treatment of this pathology is highlighted.

全文:

受限制的访问

参考

  1. Voiosu T.A., Giurcan R., Voiosu A.M., Voiosu M.R. Functional dyspepsia today. Maedica. 2013; 8(1): 68-74.
  2. Ghoshal U.C., Singh R., Chang F.Y., et al. Epidemiology of uninvestigated and functional dyspepsia in Asia: facts and fiction. J. Neurogastroenterol. Motil. 2011; 17: 235-44.
  3. Маев И.В., Самсонов А.А., Кучерявый Ю.А., Казюлин А.Н. Диспепсии: виды, причины, алгоритмы диагностики и лечения. Фарматека. 2010; 11: 91-100.
  4. Bazaldua O.V., Schneider F.D. Evaluation and management of dyspepsia. Am Fam Physician. 1999; 60(6) 1773-84.
  5. Drossman D.A. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006; 130: 1377-90.
  6. Mahadeva S., Goh K.L. Epidemiology of functional dyspepsia: a global perspective. World J. Gastroenterol. 2006; 12(17): 2661-66.
  7. Маев И.В., Самсонов А.А., Андреев Д.Н., Кочетов С.А. Дифференцированная тактика лечения синдрома функциональной диспепсии. Медицинский совет. 2012; 9: 13-20.
  8. Brun R., Kuo B. Functional dyspepsia. Therap. Adv. Gastroenterol. 2010; 3(3): 145-64.
  9. Miwa H., Watari J., Fukui H., et al. Current understanding of pathogenesis of functional dyspepsia. J. Gastroenterol. Hepatol. 2011; 26 (Suppl. 3): 53-60.
  10. Sarnelli G., Caenepeel P., Geypens B., et al. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am. J. Gastroenterol. 2003; 98: 783-88.
  11. Rahim M.K., Durr-e-Sabih, Mateen A., et al. Studies of gastric emptying time in patients with non-ulcer dyspepsia. Nucl. Med. Commun. 2007; 28: 852-58.
  12. Talley N.J., Verlinden M., Jones M. Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia ? Am. J. Gastroenterol. 2001; 96: 1422-28.
  13. Tack J., Bisschops R., Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology. 2004; 127: 1239-55.
  14. Piessevaux H., Tack J., Walrand S., et al. Intragastric distribution of a standardized meal in health and functional dyspepsia: correlation with specific symptoms. Neurogastroenterol. Motil. 2003; 15: 447-55.
  15. Keohane J., Quigley E.M.M. Functional dyspepsia: The role of visceral hypersensitivity in its pathogenesis. World J. Gastoenterol. 2006; 12: 2672-76.
  16. Vandenberghe J., Vos R., Persoons P., et al. Dyspeptic patients with visceral hypersensitivity: sensitisation of pain specific or multimodal pathways? Gut. 2005; 54: 914-19.
  17. Tack J., Caenepeel P., Fischler B., Piessevaux H., Janssens J. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology. 2001; 121: 526-35.
  18. Klatt S., Pieramico O., Guethner C. et al. Gastric hipersensitivity in nonulcer dyspepsia: an inconsistent finding. Dig. Dis. Sci. 1997; 2(4): 720-23.
  19. Samson M., Verhagen M.A., van Berge-Henegouwen G.P. et al. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology. 1999; 116: 515-20.
  20. Sarnelli G., DAlessandro A., Pesce M., et al. Genetic contribution to motility disorders of the upper gastrointestinal tract. World J. Gastrointest. Pathophysiol. 2013; 4(4): 65-73.
  21. Camilleri C.E., Carlson P.J., Camilleri M., et al. A study of candidate genotypes associated with dyspepsia in a U.S. community. Am. J. Gastroenterol. 2006; 101(3): 581 -92.
  22. van Lelyveld N., Linde J.T., Schipper M., Samsom M. Candidate genotypes associated with functional dyspepsia. Neurogastroenterol. Motil. 2008; 20(7): 767-73.
  23. Tahara T., Shibata T., Nakamura M., et al. Homozygous TRPV1 315C influences the susceptibility to functional dyspepsia. J. Clin. Gastroenterol. 2010; 44( 1 ): e 1 - 7.
  24. Маев И.В., Самсонов А.А., Андреев Д.Н., и др. Современный алгоритм диагностики и лечения синдрома функциональной диспепсии. Медицинский совет. 2013; 10: 6-10.
  25. Маев И.В., Самсонов А.А., Андреев Д.Н. Клиническое значение синдрома «перекреста» функциональной диспепсии и гастроэзофагеальной рефлюксной болезни. Клинические перспективы гастроэнтерологии, гепатологии. 2013; 5: 17-22.
  26. Miwa H., Ghoshal U.C., Gonlachanvit S., et al. Asian Consensus Report on Functional Dyspepsia. J. Neurogastroenterol. Motil. 2012l; 18(2): 150-68.
  27. Simren M., Tack J. Functional dyspepsia: evaluation and treatment. Gastroenterol. Clin. North Am. 2003; 32(2): 577-99.
  28. Lee Y.Y., Chua A.S. Role of Helicobacter pylori in Functional Dyspepsia: More Controversies Than Answers. J. Neurogastroenterol. Motil. 2013; 19(3): 417.
  29. Маев И.В., Самсонов А.А., Андреев Д.Н., и др. Клиническое значение инфекции Helicobacter pylori. Клиническая медицина. 2013; 8: 4-12.
  30. Camilleri M., Stanghellini V. Current management strategies and emerging treatments for functional dyspepsia. Nat. Rev. Gastroenterol. Hepatol. 2013; 10(3): 187-94.
  31. Moayyedi P., Soo S., Deeks J., et al. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2006; (4): CD001960.
  32. Huang X., Lv B., Zhang S., et al. Itopride therapy for functional dyspepsia: a meta-analysis. World J. Gastroenterol. 2012; 18(48): 7371 -77.
  33. Маев И.В., Андреев Д.Н., Дичева Д.Т., Гончаренко А.Ю. Фармакотерапевтические аспекты применения ингибиторов протонной помпы. Медицинский вестник МВД. 2013; 3: 9-14.
  34. Маев И.В., Кучерявый Ю.А., Данилевская Н.Н. Ингибиторы протонной помпы: кроется ли опасность при длительной терапии? Лечебное дело. 2011; 2: 16-22.
  35. Katz P.O. Optimizing medical therapy for gastroesophageal reflux disease: state of the art. Reviews Gastroenterol. Dis. 2003; 3(2): 59-69.
  36. Морозов С.В., Кучерявый Ю.А. Ингибиторы протонной помпы при синдроме функциональной диспепсии. Медицинский совет. 2012; 1: 68-9.
  37. Grudell А.В., Camilleri М., Burton D.D., Stephens D.A. Effect of a proton pump inhibitor on postprandial gastric volume, emptying and symptoms in healthy human subjects: a pilot study. Aliment Pharmacol. Ther. 2006; 24: 1037-43.
  38. Морозов С., Кучерявый Ю. Монотерапия ингибиторами протонного насоса при функциональной диспепсии. Врач. 2011; 14: 18-21.
  39. Wang W.H., Huang J.Q., Zheng G.F., et al. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clin. Gastroenterol. Hepatol. 2007; 5(2): 178-85.
  40. Маев И.В., Андреев Д.Н., Гончаренко А.Ю., Дичева Д.Т. Ингибиторы протонной помпы как основа лечения кислотозависимых заболеваний. Справочник поликлинического врача. 2013; 7-8: 42-4.
  41. Tschabitscher D., Platzer Р., Baumgartel С., Mullner M. Generic drugs: quality, efficacy, safety and interchangeability. Wien. Klin. Wochenschr. 2008; 120(3-4): 63-9.
  42. Cammarota S., Bruzzese D., Sarnelli G., et al. Proton pump inhibitors prescribing following the introduction of generic drugs. Eur. J. Clin. Invest. 2012; 42(10): 1068-78.
  43. Маев И.В., Трухманов A.C., Кучерявый Ю.А. Фармакоэкономика кислотозависимых заболеваний. Росс. журн. гастроэнтерол, гепатол, колопроктол. 2006; 3: 68-77.
  44. van Kerkhoven L.A., Laheij R.J., Aparicio N., et al. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. Clin. Gastroenterol. Hepatol. 2008; 6(7): 746-52.
  45. Talley N.J., Choung R.S., Camilleri M., et al: Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia. Aliment. Pharmacol. Ther. 2008; 27: 1122-31.
  46. Nolan M.l., Scott Li. Acotiamide: first global approval. Drugs. 2013; 73(12): 1377-83.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##